Global Ibuprofen API Market Segmentation, By Type (Standard Ibuprofen and High Potency Ibuprofen), Application (Headache, Arthritis, and Others), End User (CROs and CMOs and Pharmaceutical and Biopharmaceutical Company) – Industry Trends and Forecast to 2031.
Ibuprofen API Market Analysis and Size
The global ibuprofen API market is experiencing robust growth driven by the increasing demand for over-the-counter (OTC) pain relievers and anti-inflammatory medications. The rise in chronic diseases, such as arthritis and migraines, alongside the growing prevalence of common ailments like colds and flu, is fueling the need for effective pain management solutions. Additionally, the expansion of the pharmaceutical industry in emerging markets and the ongoing innovation in drug formulations contribute to the market's expansion. Key players in the industry are focusing on improving the purity and efficiency of ibuprofen API production to meet stringent regulatory standards and enhance product efficacy.
Ibuprofen API Market Size
Global ibuprofen API market size was valued at USD 448.74 million in 2023 and is projected to reach USD 657.96 million by 2031, with a CAGR of 4.90% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Report Scope and Market Segmentation
|
Attributes
|
Ibuprofen API Key Market Insights
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (Headache, Arthritis, and Others), End User (CROs and CMOs and Pharmaceutical and Biopharmaceutical Company)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
BASF SE (Germany), SI Group, Inc. (U.S.), BIOCAUSE Inc. (U.S.), IOL Chemicals and Pharmaceuticals Limited (India), Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China), Granules India Limited (India), LGM Pharma (U.S.), Salvavidas (India), Taj Pharmaceuticals Limited (India)
|
|
Market Opportunities
|
|
Ibuprofen API Market Definition
Ibuprofen API is the pure, active substance used in the manufacture of ibuprofen-based medications. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, and inflammation. The API is the core component that provides the therapeutic effects of ibuprofen when formulated into tablets, capsules, or other dosage forms.
Ibuprofen API Market Dynamics
Drivers
- Increasing Demand for Pain Management
As the global population ages and lifestyle-related health issues become more common, the need for reliable pain management solutions continues to grow. Chronic conditions such as arthritis, back pain, and migraines contribute to the sustained demand for nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. This heightened demand for pain relief drives the need for more ibuprofen API, ensuring that pharmaceutical companies can produce sufficient quantities to meet market requirements. The rising prevalence of chronic pain conditions and common ailments significantly boosts the demand for effective ibuprofen-based treatments.
- Rising Demand for Ibuprofen Expanding Pharmaceutical Sector
With developing economies investing more in healthcare infrastructure and increasing their pharmaceutical manufacturing capabilities, there is a rising need for active pharmaceutical ingredients, including ibuprofen. The growth in these markets is fueled by increased healthcare access, higher disposable incomes, and a growing focus on improving healthcare outcomes. Consequently, this expansion presents significant opportunities for ibuprofen API suppliers to tap into new markets and leverage the growing demand for pain management solutions. The expansion of the pharmaceutical sector, especially in emerging markets, is a key factor driving the increased demand for ibuprofen APIs.
Opportunities
- Rising OTC Medication Sales
Consumers are increasingly opting for OTC medications due to their convenience and accessibility compared to prescription drugs. This trend is fueled by a greater emphasis on self-care and the desire to manage minor health issues independently. As more people seek OTC solutions for pain relief and inflammation, the need for ibuprofen APIs rises to support the production of these widely used medications. This shift towards OTC products creates significant growth opportunities for manufacturers of ibuprofen APIs.
- Advancements in ibuprofen Drug Formulations
Ongoing innovation in drug delivery and formulation technologies is enhancing the efficacy and market appeal of ibuprofen products. Advancements such as controlled-release formulations, combination therapies, and improved absorption techniques are making ibuprofen more effective and appealing to both consumers and healthcare providers. These innovations not only improve patient compliance and therapeutic outcomes but also create new opportunities for ibuprofen API manufacturers to differentiate their products in a competitive market. The ability to offer advanced formulations that cater to specific patient needs helps drive demand for high-quality ibuprofen APIs.
Restraints/Challenges
- Fluctuating Raw Material Prices
Volatility in the prices of raw materials used in ibuprofen API production can significantly impact profitability and market stability. Key ingredients for producing ibuprofen, such as chemicals and intermediates, are subject to price fluctuations due to various factors, including supply chain disruptions, geopolitical tensions, and changes in global commodity markets. These price variations can lead to increased production costs, which may necessitate adjustments in the ibuprofen API price.
- Side Effects and Safety Concerns
Potential side effects and safety issues associated with ibuprofen can influence consumer confidence and affect market demand. While ibuprofen is widely used for pain relief and inflammation, it is associated with several adverse effects, including gastrointestinal disturbances, cardiovascular risks, and renal complications. These safety concerns can lead to regulatory scrutiny and impact public perception of the drug. Ensuring rigorous testing, transparent labeling, and comprehensive risk communication are crucial for addressing these issues.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent Developments
- In November 2022, Solara Active Pharma Sciences Limited's state-of-the-art, multipurpose API manufacturing facility in Vishakhapatnam, Andhra Pradesh, obtained Certificate of Suitability (CEP) approval from the European Directorate for the Quality of Medicine (EDQM) for ibuprofen API production
- In March 2022, Lonza invested USD 935 million in new sites in Portsmouth, New Hampshire, and Visp, Switzerland. The company also completed a laboratory expansion at its API manufacturing facility in Nansha, China
Ibuprofen API Market Scope
The market is segmented on the basis of type, application, and end user. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Standard Ibuprofen
- High Potency Ibuprofen
Application
- Headache
- Arthritis
- Others
End User
- CROs and CMOs
- Pharmaceutical and Biopharmaceutical Companies
Ibuprofen API Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country, type, application, and end user as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
Asia-Pacific is expected to dominate the market due to increased healthcare expenditure, growth in production facilities, a strong presence of pharmaceutical and biotechnological key players, a rising incidence of rheumatoid arthritis, and an overall surge in healthcare activities.
The country section of the report also provides individual market-impacting factors and changes in market regulation that affect the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Ibuprofen API Market Share Analysis
The market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the market.
Some of the major market players operating in the market are:
- BASF SE (Germany)
- SI Group, Inc. (U.S.)
- BIOCAUSE Inc. (U.S.)
- IOL Chemicals and Pharmaceuticals Limited (India)
- Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
- Granules India Limited (India)
- LGM Pharma (U.S.)
- Salvavidas (India)
- Taj Pharmaceuticals Limited (India)
SKU-